Trial Profile

Phase I/II study of CTAP101 Capsules for the treatment of vitamin D insufficiency in chronic kidney disease (CKD)

Status: Recruiting

Phase of Trial: Phase I/II

Latest Information Update: 20 Jan 2017

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Calcifediol (Primary)
Indications Vitamin D deficiency
Focus Pharmacokinetics

Most Recent Events

20 Jan 2017 According to OPKO Health website, this trial was originally conducted by Cytochroma which later on was acquired by OPKO Health and now the name changed to OPKO Renal in March 2013.
27 May 2016 New trial record

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com